Ronna Romney Sells 250 Shares of Molina Healthcare, Inc. (MOH) Stock

Molina Healthcare, Inc. (NYSE:MOH) Director Ronna Romney sold 250 shares of the stock in a transaction that occurred on Friday, December 29th. The shares were sold at an average price of $78.34, for a total value of $19,585.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

Ronna Romney also recently made the following trade(s):

  • On Friday, December 15th, Ronna Romney sold 250 shares of Molina Healthcare stock. The shares were sold at an average price of $74.53, for a total value of $18,632.50.
  • On Tuesday, November 14th, Ronna Romney sold 250 shares of Molina Healthcare stock. The shares were sold at an average price of $77.68, for a total value of $19,420.00.

Shares of Molina Healthcare, Inc. (NYSE MOH) traded down $1.26 on Friday, hitting $76.68. The company’s stock had a trading volume of 415,847 shares, compared to its average volume of 1,115,304. Molina Healthcare, Inc. has a twelve month low of $42.56 and a twelve month high of $80.74. The firm has a market cap of $4,377.97, a P/E ratio of -12.63 and a beta of 0.97. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 1.06.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Thursday, November 2nd. The company reported ($1.62) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($1.85). Molina Healthcare had a positive return on equity of 17.76% and a negative net margin of 1.76%. The company had revenue of $5.03 billion during the quarter, compared to analyst estimates of $4.95 billion. During the same period last year, the business earned $0.85 earnings per share. The firm’s revenue was up 10.7% compared to the same quarter last year. equities analysts expect that Molina Healthcare, Inc. will post -3.88 EPS for the current year.

Several research firms recently commented on MOH. Zacks Investment Research raised Molina Healthcare from a “sell” rating to a “hold” rating in a research note on Monday, November 6th. Morgan Stanley increased their price objective on Molina Healthcare from $68.00 to $89.00 and gave the company an “overweight” rating in a research note on Friday, November 3rd. ValuEngine downgraded Molina Healthcare from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Raymond James Financial reissued a “hold” rating on shares of Molina Healthcare in a research note on Friday, December 8th. Finally, Jefferies Group increased their price objective on Molina Healthcare from $64.00 to $74.00 and gave the company a “hold” rating in a research note on Friday, November 3rd. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $64.25.

Institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. grew its holdings in shares of Molina Healthcare by 1.9% during the 2nd quarter. Vanguard Group Inc. now owns 3,619,435 shares of the company’s stock worth $250,392,000 after purchasing an additional 66,206 shares during the period. Jana Partners LLC grew its holdings in shares of Molina Healthcare by 52.5% during the 3rd quarter. Jana Partners LLC now owns 2,125,351 shares of the company’s stock worth $146,139,000 after purchasing an additional 731,992 shares during the period. Tiedemann Wealth Management LLC grew its holdings in shares of Molina Healthcare by 7.8% during the 3rd quarter. Tiedemann Wealth Management LLC now owns 1,440,066 shares of the company’s stock worth $135,000 after purchasing an additional 103,775 shares during the period. Northern Trust Corp grew its holdings in shares of Molina Healthcare by 14.5% during the 2nd quarter. Northern Trust Corp now owns 900,946 shares of the company’s stock worth $62,328,000 after purchasing an additional 113,808 shares during the period. Finally, Rothschild Asset Management Inc. grew its holdings in shares of Molina Healthcare by 6.1% during the 3rd quarter. Rothschild Asset Management Inc. now owns 706,683 shares of the company’s stock worth $48,592,000 after purchasing an additional 40,737 shares during the period. 96.22% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece can be accessed at https://www.com-unik.info/2017/12/31/ronna-romney-sells-250-shares-of-molina-healthcare-inc-moh-stock.html.

Molina Healthcare Company Profile

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Insider Buying and Selling by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit